Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-17-013048
Filing Date
2017-11-14
Accepted
2017-11-14 10:38:40
Documents
3
Period of Report
2017-05-22
Effectiveness Date
2017-11-14

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 192334
2 image_001.jpg GRAPHIC 76399
3 image_002.jpg GRAPHIC 62712
  Complete submission text file 0001493152-17-013048.txt   385180
Mailing Address 350 5TH AVENUE SUITE 4740 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 4740 NEW YORK NY 10118 212-330-8500
DAXOR CORP (Filer) CIK: 0000027367 (see all company filings)

EIN.: 132682108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 811-22684 | Film No.: 171199113
SIC: 3841 Surgical & Medical Instruments & Apparatus